{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:19:43Z","timestamp":1772198383285,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900281"],"award-info":[{"award-number":["81900281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2017YFC1308105"],"award-info":[{"award-number":["2017YFC1308105"]}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2018M630585"],"award-info":[{"award-number":["2018M630585"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Patent ductus arteriosus (PDA) is a congenital heart defect with an unclear etiology that occurs commonly among newborns. Adequately understanding the molecular pathogenesis of PDA can contribute to improved treatment and prevention. Plasma proteins may provide evidence to explore the molecular mechanisms of abnormal cardiac development.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Isobaric tags for relative and absolute quantitation (iTRAQ) proteomics technology was used to measure different plasma proteins in PDA patients (<jats:italic>n<\/jats:italic>\u2009=\u20094) and controls (<jats:italic>n<\/jats:italic>\u2009=\u20094). The candidate protein was validated by ELISA and Western blot (WB) assays in a larger sample. Validation of the location and expression of this protein was performed in mouse heart sections.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There were three downregulated proteins and eight upregulated proteins identified in the iTRAQ proteomics data. Among these, protein disulfide-isomerase A6 (PDIA6) was further analyzed for validation. The plasma PDIA6 concentrations (3.2\u2009\u00b1\u20090.7\u2009ng\/ml) in PDA patients were significantly lower than those in normal controls (5.8\u2009\u00b1\u20091.2\u2009ng\/ml). In addition, a WB assay also supported these results. PDIA6 was widely expressed in mouse heart outflow tract on embryonic day 14.5.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Plasma proteomics profiles suggested novel candidate molecular markers for PDA. The findings may allow development of a new strategy to investigate the mechanism and etiology of PDA.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13052-020-00831-6","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:02:53Z","timestamp":1589878973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Proteomics analysis of plasma protein changes in patent ductus arteriosus patients"],"prefix":"10.1186","volume":"46","author":[{"given":"Cheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuming","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"17","key":"831_CR1","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.105.592063","volume":"114","author":"DJ Schneider","year":"2006","unstructured":"Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873\u201382.","journal-title":"Circulation"},{"issue":"6","key":"831_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/0002-8703(94)90415-4","volume":"127","author":"TR Lloyd","year":"1994","unstructured":"Lloyd TR, Beekman RH 3rd. Clinically silent patent ductus arteriosus. Am Heart J. 1994;127(6):1664\u20135.","journal-title":"Am Heart J"},{"issue":"3","key":"831_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1139\/y73-031","volume":"51","author":"F Coceani","year":"1973","unstructured":"Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973;51(3):220\u20135.","journal-title":"Can J Physiol Pharmacol"},{"key":"831_CR4","doi-asserted-by":"crossref","unstructured":"Hung YC, Yeh JL, Hsu JH. Molecular mechanisms for regulating postnatal Ductus Arteriosus closure. Int J Mol Sci. 2018;19(7).","DOI":"10.3390\/ijms19071861"},{"issue":"9224","key":"831_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(00)02452-1","volume":"356","author":"E Michelakis","year":"2000","unstructured":"Michelakis E, Rebeyka I, Bateson J, Olley P, Puttagunta L, Archer S. Voltage-gated potassium channels in human ductus arteriosus. Lancet. 2000;356(9224):134\u20137.","journal-title":"Lancet"},{"issue":"4","key":"831_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/sj.bjp.0705092","volume":"138","author":"A Leonhardt","year":"2003","unstructured":"Leonhardt A, Glaser A, Wegmann M, Schranz D, Seyberth H, Nusing R. Expression of prostanoid receptors in human ductus arteriosus. Br J Pharmacol. 2003;138(4):655\u20139.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"831_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/ajplegacy.1972.222.4.841","volume":"222","author":"FS Fay","year":"1972","unstructured":"Fay FS, Cooke PH. Guinea pig ductus arteriosus. II. Irreversible closure after birth. Am J Physiol. 1972;222(4):841\u20139.","journal-title":"Am J Physiol"},{"issue":"2","key":"831_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.semperi.2011.09.019","volume":"36","author":"H Hajj","year":"2012","unstructured":"Hajj H, Dagle JM. Genetics of patent ductus arteriosus susceptibility and treatment. Semin Perinatol. 2012;36(2):98\u2013104.","journal-title":"Semin Perinatol"},{"issue":"2","key":"831_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3892\/mmr.2013.1847","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Li P, Chen S, Xi L, Guo Y, Guo A, Sun K. Influence of genes and the environment in familial congenital heart defects. Mol Med Rep. 2014;9(2):695\u2013700.","journal-title":"Mol Med Rep"},{"issue":"5","key":"831_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/14789450.2014.926224","volume":"11","author":"S Filip","year":"2014","unstructured":"Filip S, Pontillo C, Peter Schanstra J, Vlahou A, Mischak H, Klein J. Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases. Expert Rev Proteomics. 2014;11(5):535\u201348.","journal-title":"Expert Rev Proteomics"},{"issue":"12","key":"831_CR11","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1111\/jcmm.13912","volume":"22","author":"L Huang","year":"2018","unstructured":"Huang L, Li L, Yang T, Li W, Song L, Meng X, Gu Q, Xiong C, He J. Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease. J Cell Mol Med. 2018;22(12):6249\u201361.","journal-title":"J Cell Mol Med"},{"key":"831_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cbpa.2019.01.001","volume":"48","author":"KM Dorr","year":"2019","unstructured":"Dorr KM, Conlon FL. Proteomic-based approaches to cardiac development and disease. Curr Opin Chem Biol. 2019;48:150\u20137.","journal-title":"Curr Opin Chem Biol"},{"issue":"4","key":"831_CR13","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.athoracsur.2013.11.069","volume":"97","author":"C Xuan","year":"2014","unstructured":"Xuan C, Gao G, Yang Q, Wang XL, Liu ZG, Liu XC, He GW. Proteomic study reveals plasma protein changes in congenital heart diseases. Ann Thorac Surg. 2014;97(4):1414\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"11\u201312","key":"831_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/prca.201400166","volume":"9","author":"X Zhang","year":"2015","unstructured":"Zhang X, Wang K, Yang Q, Wang J, Xuan C, Liu XC, Liu ZG, He GW. Acute phase proteins altered in the plasma of patients with congenital ventricular septal defect. Proteomics Clin Appl. 2015;9(11\u201312):1087\u201396.","journal-title":"Proteomics Clin Appl"},{"issue":"5","key":"831_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/omi.2018.0033","volume":"22","author":"NE Thomford","year":"2018","unstructured":"Thomford NE, Dzobo K, Yao NA, Chimusa E, Evans J, Okai E, Kruszka P, Muenke M, Awandare G, Wonkam A, Dandara C. Genomics and Epigenomics of congenital heart defects: expert review and lessons learned in Africa. OMICS. 2018;22(5):301\u201321.","journal-title":"OMICS"},{"key":"831_CR16","first-page":"185","volume":"482","author":"L Chen","year":"2018","unstructured":"Chen L, Guan J, Wei Q, Yuan Z, Zhang M. Potential role of \"omics\" technique in prenatal diagnosis of congenital heart defects, Clinica chimica acta. Int J Clin Chem. 2018;482:185\u201390.","journal-title":"Int J Clin Chem"},{"issue":"5","key":"831_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/mas.21550","volume":"37","author":"R Moulder","year":"2018","unstructured":"Moulder R, Bhosale SD, Goodlett DR, Lahesmaa R. Analysis of the plasma proteome using iTRAQ and TMT-based isobaric labeling. Mass Spectrom Rev. 2018;37(5):583\u2013606.","journal-title":"Mass Spectrom Rev"},{"key":"831_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jprot.2017.03.017","volume":"171","author":"FS Wang","year":"2018","unstructured":"Wang FS, Dong SR, Zhang HY, Wang SY. Putative model based on iTRAQ proteomics for Spirulina morphogenesis mechanisms. J Proteome. 2018;171:73\u201380.","journal-title":"J Proteome"},{"issue":"3","key":"831_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1021\/pr050405o","volume":"5","author":"WW Wu","year":"2006","unstructured":"Wu WW, Wang G, Baek SJ, Shen RF. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF\/TOF. J Proteome Res. 2006;5(3):651\u20138.","journal-title":"J Proteome Res"},{"issue":"1","key":"831_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1172\/JCI58344","volume":"122","author":"H Shen","year":"2012","unstructured":"Shen H, Song Y, Colangelo CM, Wu T, Bruce C, Scabia G, Galan A, Maffei M, Goldstein DR. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest. 2012;122(1):383\u20137.","journal-title":"J Clin Invest"},{"issue":"5","key":"831_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1189\/jlb.1MR0114-068R","volume":"96","author":"N Cox","year":"2014","unstructured":"Cox N, Pilling D, Gomer RH. Serum amyloid P: a systemic regulator of the innate immune response. J Leukoc Biol. 2014;96(5):739\u201343.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"831_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.HYP.0000112424.06921.52","volume":"43","author":"ML Summar","year":"2004","unstructured":"Summar ML, Gainer JV, Pretorius M, Malave H, Harris S, Hall LD, Weisberg A, Vaughan DE, Christman BW, Brown NJ. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension. 2004;43(2):186\u201391.","journal-title":"Hypertension"},{"issue":"11","key":"831_CR23","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1089\/ars.2009.2466","volume":"11","author":"F Hatahet","year":"2009","unstructured":"Hatahet F, Ruddock LW. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal. 2009;11(11):2807\u201350.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"831_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.molcel.2014.01.004","volume":"53","author":"D Eletto","year":"2014","unstructured":"Eletto D, Eletto D, Dersh D, Gidalevitz T, Argon Y. Protein disulfide isomerase A6 controls the decay of IRE1alpha signaling via disulfide-dependent association. Mol Cell. 2014;53(4):562\u201376.","journal-title":"Mol Cell"},{"issue":"2","key":"831_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1096\/fj.15-275883","volume":"30","author":"D Eletto","year":"2016","unstructured":"Eletto D, Eletto D, Boyle S, Argon Y. PDIA6 regulates insulin secretion by selectively inhibiting the RIDD activity of IRE1. FASEB J. 2016;30(2):653\u201365.","journal-title":"FASEB J"},{"issue":"329","key":"831_CR26","doi-asserted-by":"publisher","first-page":"ra54","DOI":"10.1126\/scisignal.2004983","volume":"7","author":"J Groenendyk","year":"2014","unstructured":"Groenendyk J, Peng Z, Dudek E, Fan X, Mizianty MJ, Dufey E, Urra H, Sepulveda D, Rojas-Rivera D, Lim Y, Kim DH, Baretta K, Srikanth S, Gwack Y, Ahnn J, Kaufman RJ, Lee SK, Hetz C, Kurgan L, Michalak M. Interplay between the oxidoreductase PDIA6 and microRNA-322 controls the response to disrupted endoplasmic reticulum calcium homeostasis. Sci Signal. 2014;7(329):ra54.","journal-title":"Sci Signal"},{"issue":"6","key":"831_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1139\/Y09-032","volume":"87","author":"D Prins","year":"2009","unstructured":"Prins D, Michalak M. Endoplasmic reticulum proteins in cardiac development and dysfunction. Can J Physiol Pharmacol. 2009;87(6):419\u201325.","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"831_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biocel.2008.06.020","volume":"41","author":"Y Qiu","year":"2009","unstructured":"Qiu Y, Michalak M. Transcriptional control of the calreticulin gene in health and disease. Int J Biochem Cell Biol. 2009;41(3):531\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"831_CR29","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1091\/mbc.e07-03-0275","volume":"18","author":"S Wanderling","year":"2007","unstructured":"Wanderling S, Simen BB, Ostrovsky O, Ahmed NT, Vogen SM, Gidalevitz T, Argon Y. GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion. Mol Biol Cell. 2007;18(10):3764\u201375.","journal-title":"Mol Biol Cell"},{"issue":"13","key":"831_CR30","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.1074\/jbc.M505784200","volume":"281","author":"C Mao","year":"2006","unstructured":"Mao C, Tai WC, Bai Y, Poizat C, Lee AS. In vivo regulation of Grp78\/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J Biol Chem. 2006;281(13):8877\u201387.","journal-title":"J Biol Chem"},{"issue":"2","key":"831_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.yjmcc.2012.05.005","volume":"53","author":"JA Vekich","year":"2012","unstructured":"Vekich JA, Belmont PJ, Thuerauf DJ, Glembotski CC. Protein disulfide isomerase-associated 6 is an ATF6-inducible ER stress response protein that protects cardiac myocytes from ischemia\/reperfusion-mediated cell death. J Mol Cell Cardiol. 2012;53(2):259\u201367.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-020-00831-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T23:43:18Z","timestamp":1621381398000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-00831-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-00831-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study approval and ethical clearance was obtained from the Children\u2019s Hospital of Nanjing Medical University. Written consent was obtained from the guardian of the child prior to data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}